Director Robert Schriesheim sells 5,000 Houlihan Lokey (HLI) shares

Rhea-AI Filing Summary

Houlihan Lokey, Inc. director Robert A. Schriesheim reported selling 5,000 shares of Class A common stock on February 6, 2026, at a price of $170.86 per share. After this transaction, he beneficially owns 27,982 shares of Houlihan Lokey common stock, held in direct ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SCHRIESHEIM ROBERT A

(Last) (First) (Middle)

C/O HOULIHAN LOKEY, INC.

10250 CONSTELLATION BLVD., 5TH FLOOR

(Street)

LOS ANGELES CA 90067

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HOULIHAN LOKEY, INC. [ HLI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
CLASS A COMMON STOCK	02/06/2026		S		5,000	D	$170.86	27,982	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	J. Lindsey Alley, Attorney-in-Fact for Robert Schriesheim	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did HLI director Robert Schriesheim report?

Director Robert A. Schriesheim reported selling 5,000 shares of Houlihan Lokey Class A common stock. The sale occurred on February 6, 2026, and was reported on a Form 4 insider trading filing, which discloses changes in his beneficial ownership.

At what price were the Houlihan Lokey (HLI) shares sold by the director?

The 5,000 Houlihan Lokey Class A shares were sold at $170.86 per share. This transaction price, disclosed in the Form 4, is used to calculate the total value of the director’s reported sale on that date.

How many HLI shares does Robert Schriesheim own after this Form 4 sale?

After the reported sale, Robert A. Schriesheim beneficially owns 27,982 shares of Houlihan Lokey Class A common stock. The Form 4 notes these shares as held in direct ownership following the February 6, 2026 transaction.

What is the ownership type for Robert Schriesheim’s remaining HLI shares?

The remaining 27,982 shares of Houlihan Lokey Class A common stock are reported as held in direct ownership. The Form 4 does not list any indirect ownership entities or special footnote disclosures for these holdings.

What role does Robert Schriesheim have at Houlihan Lokey (HLI)?

Robert A. Schriesheim is identified as a director of Houlihan Lokey, Inc. in the filing. The Form 4’s relationship section confirms his status as a director and indicates he is not reported as a 10% owner or officer of the company.

Who signed the Form 4 reporting the HLI insider transaction?

The Form 4 was signed by J. Lindsey Alley acting as Attorney-in-Fact for Robert Schriesheim. This indicates the filing was submitted under a power of attorney on February 9, 2026, as disclosed in the signature block.